These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Mercante G; Frasoldati A; Pedroni C; Formisano D; Renna L; Piana S; Gardini G; Valcavi R; Barbieri V Thyroid; 2009 Jul; 19(7):707-16. PubMed ID: 19348581 [TBL] [Abstract][Full Text] [Related]
3. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522 [TBL] [Abstract][Full Text] [Related]
4. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up. Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547 [TBL] [Abstract][Full Text] [Related]
5. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer. Zhao H; Huang T; Li H Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667 [TBL] [Abstract][Full Text] [Related]
7. Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study. ESES Vienna presentation. Hillenbrand A; Varhaug JE; Brauckhoff M; Pandev R; Haufe S; Dotzenrath C; Köberle R; Hoffmann R; Klein G; Kadmon M; Negele T; Hagieva T; Henne-Bruns D; Luster M; Weber T Langenbecks Arch Surg; 2010 Sep; 395(7):851-8. PubMed ID: 20683623 [TBL] [Abstract][Full Text] [Related]
8. Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients. Vasileiadis I; Karatzas T; Vasileiadis D; Kapetanakis S; Charitoudis G; Karakostas E; Kouraklis G Head Neck; 2014 Apr; 36(4):564-70. PubMed ID: 23780707 [TBL] [Abstract][Full Text] [Related]
9. [Draft of the best medical treatment in patients with low-risk thyroid cancer]. Vlček P; Nováková D; Vejvalka J; Zimák J; Křenek M; Vošmiková K; Smutný S; Bavor P; Astl J; Lukáš J Vnitr Lek; 2015 Sep; 61(9):769-77. PubMed ID: 26465275 [TBL] [Abstract][Full Text] [Related]
10. [Risk Factors for central lymph node metastasis in 1 988 papillary thyroid microcarcinoma patients]. Li XJ; Yang L; Ma BL Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(1):52-57. PubMed ID: 29774686 [No Abstract] [Full Text] [Related]
11. Clinicopathologic Factors and Thyroid Nodule Sonographic Features for Predicting Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study of 1204 Patients. Wang WH; Xu SY; Zhan WW J Ultrasound Med; 2016 Nov; 35(11):2475-2481. PubMed ID: 27794131 [TBL] [Abstract][Full Text] [Related]
12. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma. Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312 [TBL] [Abstract][Full Text] [Related]
13. [Is total thyroidectomy and lymph node excision as therapy of differentiated thyroid gland carcinomas in childhood justified?]. Witte J; Goretzki PE; Simon D; Röher HD Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():196-8. PubMed ID: 9101829 [TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of papillary thyroid microcarcinoma less than or equal to 5 mm on ultrasonography. Lee HS; Park HS; Kim SW; Choi G; Park HS; Hong JC; Lee SG; Baek SM; Lee KD Eur Arch Otorhinolaryngol; 2013 Nov; 270(11):2969-74. PubMed ID: 23873032 [TBL] [Abstract][Full Text] [Related]
15. Treatment for microcarcinoma of the thyroid--clinical experience. Küçük NO; Tari P; Tokmak E; Aras G Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for aggressiveness in subcentimeter papillary thyroid carcinoma: impact of tumor size and lymph node metastases. Kayhan Y; Azizova L; Yılmaz M; Bakış M; Kefeli M; Kan EK; Atmaca A; Çolak R Arch Endocrinol Metab; 2024; 68():e230422. PubMed ID: 39420875 [TBL] [Abstract][Full Text] [Related]
17. Prediction of central lymph node metastasis in patientswith thyroid papillary microcarcinoma. Akın Ş; Yazgan Aksoy D; Akın S; Kılıç M; Yetişir F; Bayraktar M Turk J Med Sci; 2017 Dec; 47(6):1723-1727. PubMed ID: 29306230 [TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics of Subtypes of Follicular Variant Papillary Thyroid Carcinoma. Kim MJ; Won JK; Jung KC; Kim JH; Cho SW; Park DJ; Park YJ Thyroid; 2018 Mar; 28(3):311-318. PubMed ID: 29343212 [TBL] [Abstract][Full Text] [Related]
19. Sonographic features of papillary thyroid microcarcinoma predicting high-volume central neck lymph node metastasis. Huang XP; Ye TT; Zhang L; Liu RF; Lai XJ; Wang L; Yang M; Zhang B; Li XY; Liu ZW; Xia Y; Jiang YX Surg Oncol; 2018 Jun; 27(2):172-176. PubMed ID: 29937168 [TBL] [Abstract][Full Text] [Related]
20. Risk factors of distant metastasis in the follicular variant of papillary thyroid carcinoma. Li YR; Chen ST; Hseuh C; Chao TC; Ho TY; Lin JD J Formos Med Assoc; 2016 Aug; 115(8):665-71. PubMed ID: 26239193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]